Lipopolysaccharides (LPSs) as Potent Neurotoxic Glycolipids in Alzheimer’s Disease (AD) is a research paper published in International Journal of Molecular Sciences (2022). On theSindex it has a DataRank of 0. It has been cited 57 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Research to Prevent Blindness (RPB)
Grant: LSU Ophthalmology
Research to Prevent Blindness (RPB)
Grant: 2021-2022
Research to Prevent Blindness (RPB)
Grant: NEI EY006311
Research to Prevent Blindness (RPB)
Grant: NIA AG18031
Research to Prevent Blindness (RPB)
Grant: NIA AG038834
National Institutes of Health
Grant: 2R01EY006311-02A1
OCULAR HSV: LATENCY, REACTIVATION, &RECURRENCE
National Institutes of Health
Grant: 5R01AG038834-04
Micro RNA-146a (miRNA-146a) signaling in Alzheimers disease (AD)
National Institutes of Health
Grant: 5R01AG018031-03
Gene Expression in Alzheimers Disease
FWCI
5.39
Citation Percentile
1.0%
Influential Citations
2
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Epigallocatechin-3-gallate protects bovine ruminal epithelial cells against lipopolysaccharide-induced inflammatory damage by activating autophagy
Additional file 1 of Epigallocatechin-3-gallate protects bovine ruminal epithelial cells against lipopolysaccharide-induced inflammatory damage by activating autophagy